Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/CRINETICS-PHARMACEUTICALS-44965100/news/Crinetics-Pharmaceuticals-Presents-Data-from-Phase-2-Study-of-Paltusotine-in-Carcinoid-Syndrome-46154237/?utm_source=whatsapp&utm_medium=social&utm_campaign=share